Saturn V Capital Management LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Saturn V Capital Management LP held in its portfolio 20 assets valued at $544,900,849 (i.e. $544.90M).

The most valuable assets in the portfolio included: ABIVAX SA ($87.55M), AMYLYX PHARMACEUTICALS INC ($54.32M), and COGENT BIOSCIENCES INC ($43.23M).

The chart below shows the top 10 valuable assets, and the table below shows the top 20 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Saturn V Capital Management LP Portfolio

ABIVAX SA

AMYLYX PHARMACEUTICALS INC

COGENT BIOSCIENCES INC

JAZZ PHARMACEUTICALS PLC

VAXCYTE INC

DYNE THERAPEUTICS INC

PHARVARIS N V

CELCUITY INC

ALUMIS INC

DISC MEDICINE INC

Saturn V Capital Management LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ABIVAX SA	649179	87545034	SPONSORED ADS
AMYLYX PHARMACEUTICALS INC	4496487	54317563	COM
COGENT BIOSCIENCES INC	1217064	43230113	COM
JAZZ PHARMACEUTICALS PLC	248070	42171900	SHS USD
VAXCYTE INC	798940	36863092	COM
DYNE THERAPEUTICS INC	1788616	34985329	COM
PHARVARIS N V	1140033	31635916	COM
CELCUITY INC	317095	31627055	COM
ALUMIS INC	3135953	30606901	COM
DISC MEDICINE INC	298429	23698247	COM
X4 PHARMACEUTICALS INC	5800530	23202120	COM NEW
MONOPAR THERAPEUTICS INC	325701	21268275	COM NEW
INVIVYD INC	7735386	19106403	COM
OCULAR THERAPEUTIX INC	1504880	18269243	COM
IMMIX BIOPHARMA INC	2999169	15685654	COM
OCULIS HOLDING AG	516761	10319717	ORDINARY SHARES
INHIBIKASE THERAPEUTICS INC	3856799	7906438	COM NEW
CENTESSA PHARMACEUTICALS PLC	282692	7070127	SPONSORED ADS
OVID THERAPEUTICS INC	2500000	4075000	COM
INVENTIVA SA	283166	1316722	ADS